Clinical trial
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin…
NCT00113477 · Oslo University Hospital, Other · Completed
Key facts
| NCT number | NCT00113477 |
|---|---|
| Title | The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy |
| Official title | A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | Pharma Nord Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Statin Therapy |
| Intervention type | Drug |
| Interventions | Q10, Selen |
| Enrollment | 40 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 9, 2005 |
| Last update posted | Jul 1, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: